Medical News

RSS

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

Affymetrix, Inc. today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan FFPE Express Service data analysis.

27 May 2011

Recombinant partners with U.S. Department of Veterans Affairs in genomic research program

Recombinant Data Corp., a Massachusetts-based healthcare data warehousing and clinical intelligence solutions provider, today announced its continued contributions to innovative IT tools for clinical research, through the company's key role in the U.S. Department of Veterans Affairs' Million Veteran Program (MVP).

27 May 2011

Size of bodies has a profound effect on perception of surrounding space

Imagine shrinking to the size of a doll in your sleep. When you wake up, will you perceive yourself as tiny or the world as being populated by giants? Researchers at Karolinska Institutet in Sweden may have found the answer.

27 May 2011

Parties differ on selling insurance across state lines

Basic consumer protections that exist in almost every state would be eroded if insurance companies could sell policies across state lines, Democrats said Wednesday.

27 May 2011

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Currently, about 30 per cent of patients who receive oral surgery have their cancer recur. But a new, Canada-wide surgical trial using a new approach to remove tumours and pre-cancerous cells from the mouths of those diagnosed with early-stage oral cancer offers new hope for patients.

27 May 2011

Hysterectomy procedures will continue to decline due to advantages of less-invasive alternatives: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).

27 May 2011

Researchers convert human skin cells directly into functional neurons within four to five weeks

Human skin cells can be converted directly into functional neurons in a period of four to five weeks with the addition of just four proteins, according to a study by researchers at the Stanford University School of Medicine.

27 May 2011

Patients with body dysmorphic disorder have less brain activity in visual processing

People suffering from body dysmorphic disorder, or BDD - a severe mental illness characterized by debilitating misperceptions that one appears disfigured and ugly - process visual information abnormally, even when looking at inanimate objects, according to a new UCLA study.

27 May 2011

'Spongy' silicon biosensor shows promise for medical, security applications

Vanderbilt University engineers have created a "spongy" silicon biosensor that shows promise not only for medical diagnostics, but also for the detection of dangerous toxins and other tiny molecules in the environment.

27 May 2011

Sanofi-Aventis, Medtronic under scrutiny in press reports

ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.

27 May 2011

Difficulty to learn maths linked to neurocognitive disorder

Students who struggle to learn mathematics may have a neurocognitive disorder that inhibits the acquisition of basic numerical and arithmetic concepts, according to a new paper by University of Minnesota and British researchers. Called developmental dyscalculia, the disorder affects roughly the same number of people as dyslexia but has received much less attention (and research funding).

27 May 2011

GOP presidential hopefuls offer Medicare, health reform opinions

Pawlenty offers his Medicare policy positions with care while California Healthline looks at steps he took during his tenure as Minnesota's governor to refashion the state's health system. Meanwhile, Newt Gingrich vows to repeal the health law.

27 May 2011

Two new hepatitis C drugs effectively improve cure rates of African Americans

Two new drugs just approved by the Food and Drug Administration to treat hepatitis C genotype 1 significantly improved the cure rates of patients. One of the drugs was extremely effective in treating African Americans.

27 May 2011

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Data presented today at the EULAR 2011 Annual Congress demonstrated that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.

27 May 2011

Disparities based on race and ethnic origin exist in every aspect of stroke care

Disparities between racial/ethnic minorities and whites cross all aspects of stroke care, according to an American Heart Association/American Stroke Association scientific statement.

27 May 2011

Tufts Health Plan receives prestigious advertising awards for new health and wellness promotion

Tufts Health Plan was recently honored for excellence in advertising in two national competitions, winning a total of three awards.

27 May 2011

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

The National Heart, Lung, and Blood Institute of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.

27 May 2011

Mylan plans to change name of Matrix Laboratories

Mylan Inc. today announced that it plans to rebrand its Hyderabad, India-based subsidiary Matrix Laboratories Limited as Mylan.

27 May 2011

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

Next round of arguments in health law appeals process will be marked by tough questioning

The Obama administration can expect tough questioning from the three appeals judges chosen Wednesday to hear the multi-state challenge to the health care reform law. Unlike the three Democratic appointees who heard the first appeals arguments in Richmond earlier this month, the 11th Circuit panel includes judges appointed by presidents of both parties. The Atlanta-based court is slated to hear appeal arguments June 8.

27 May 2011

Medical News

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

Recombinant partners with U.S. Department of Veterans Affairs in genomic research program

Size of bodies has a profound effect on perception of surrounding space

Parties differ on selling insurance across state lines

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Hysterectomy procedures will continue to decline due to advantages of less-invasive alternatives: MRG

Researchers convert human skin cells directly into functional neurons within four to five weeks

Patients with body dysmorphic disorder have less brain activity in visual processing

'Spongy' silicon biosensor shows promise for medical, security applications

Sanofi-Aventis, Medtronic under scrutiny in press reports

Difficulty to learn maths linked to neurocognitive disorder

GOP presidential hopefuls offer Medicare, health reform opinions

Two new hepatitis C drugs effectively improve cure rates of African Americans

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Disparities based on race and ethnic origin exist in every aspect of stroke care

Tufts Health Plan receives prestigious advertising awards for new health and wellness promotion

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

Mylan plans to change name of Matrix Laboratories

Research provides new understanding of how heroin affects the brain

Next round of arguments in health law appeals process will be marked by tough questioning

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News